These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6334064)

  • 21. Effect of administration of 5-hydroxytryptophan and an inhibitor of L-aromatic amino acid decarboxylase on glucose metabolism in rat brain.
    Wong KL; Tyce GM
    Neurochem Res; 1979 Apr; 4(2):277-87. PubMed ID: 313531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apical and basal uptake of L-dopa and L-5-HTP and their corresponding amines, dopamine and 5-HT, in OK cells.
    Vieira-Coelho MA; Soares-da-Silva P
    Am J Physiol; 1997 May; 272(5 Pt 2):F632-9. PubMed ID: 9176374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further observations on the use of 5-hydroxytryptophan in a child with Lesch-Nyhan syndrome.
    Anders TF; Cann HM; Ciaranello RD; Barchas JD; Berger PA
    Neuropadiatrie; 1978 May; 9(2):157-66. PubMed ID: 308621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human sleep and 5-HTP. Effects of repeated high doses and of association with benserazide (RO.04.4602).
    Autret A; Minz M; Bussel B; Cathala HP; Castaigne P
    Electroencephalogr Clin Neurophysiol; 1976 Oct; 41(4):408-13. PubMed ID: 60227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebellar ataxia.
    Klein P
    Arch Neurol; 1989 Nov; 46(11):1166. PubMed ID: 2818245
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of substances modifying serotonin metabolism in the treatment of narco-cataplexy (considerations on 5 cases)].
    Testa G; Saia A; Chemello R
    Riv Neurol; 1979; 49(1):62-71. PubMed ID: 451399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that the effects of 5-hydroxytryptophan on the secretion of ACTH and growth hormone in dogs are not mediated by central release of serotonin.
    Zimmermann H; Kaplan SL; Ganong WF
    Neuroendocrinology; 1982 Jan; 34(1):27-31. PubMed ID: 6276803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interactions of cerebral serotonin and catecholamines].
    Watanabe Y
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):365-83. PubMed ID: 6195056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a decarboxylase inhibitor on the Dopa and 5-HTP induced changes in the locomotor-like discharge pattern of rabbit hind limb nerves.
    Viala D; Buser P
    Psychopharmacologia; 1974; 40(3):225-33. PubMed ID: 4548539
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic developments in chronic ataxias].
    Buompadre MC
    Medicina (B Aires); 2013; 73 Suppl 1():49-54. PubMed ID: 24072051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic trial in a family with late cerebellar atrophy].
    Gracia Naya M; Pina Latorre MA
    Neurologia; 1991 May; 6(5):188-9. PubMed ID: 1908256
    [No Abstract]   [Full Text] [Related]  

  • 32. [Electrophysiologic analysis of the selectivity of action of anticholinesterase preparations in hereditary ataxias].
    Avakian GN; Groppa SA; Shakhnovich VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(6):892-6. PubMed ID: 3751424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of 5-hydroxytryptophan (5-HTP) in the regulation of the sleep/wake cycle in parachlorophenylalanine (p-CPA) pretreated rat: a multiple approach study.
    Touret M; Sarda N; Gharib A; Geffard M; Jouvet M
    Exp Brain Res; 1991; 86(1):117-24. PubMed ID: 1836762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin precursors in chronic primary headache. A double-blind cross-over study with L-5-hydroxytryptophan vs. placebo.
    De Benedittis G; Massei R
    J Neurosurg Sci; 1985; 29(3):239-48. PubMed ID: 3913752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased GABA receptor binding in dominantly-inherited cerebellar ataxias.
    Kish SJ; Perry TL; Hornykiewicz O
    Brain Res; 1983 Jun; 269(2):370-3. PubMed ID: 6309324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation between the stimulus effects of l-5-hydroxytryptophan and LSD.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Jan; 108(2):179-86. PubMed ID: 3156756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of synthetic pharmacotherapy for recessive cerebellar ataxias.
    Beaudin M; Dupre N; Manto M
    Expert Rev Neurother; 2024 Sep; 24(9):897-912. PubMed ID: 38980086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
    Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buspirone, a serotonergic 5-HT1A agonist, is active in cerebellar ataxia. A new fact in favor of the serotonergic theory of ataxia.
    Trouillas P; Xie J; Adeleine P
    Prog Brain Res; 1997; 114():589-99. PubMed ID: 9193169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of 1-5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man.
    Lancranjan I; Wirz-Justice A; Pühringer W; Del Pozo E
    J Clin Endocrinol Metab; 1977 Sep; 45(3):588-93. PubMed ID: 302840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.